Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Liabilities and Shareholders Equity (2014 - 2026)

Lantheus Holdings (LNTH) posted quarterly Liabilities and Shareholders Equity of $2.3 billion for Q1 2026, up 14.18% year-over-year from $2.1 billion in Q1 2025, and up 5.35% quarter-over-quarter from $2.2 billion in Q4 2025.

Lantheus Holdings (LNTH) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Liabilities and Shareholders Equity for 13 consecutive years, with $2.3 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 14.18% year-over-year to $2.3 billion; the TTM figure through Mar 2026 stood at $9.0 billion (up 11.73% YoY), while the FY2025 annual figure was $2.2 billion, up 12.48% from the prior year.
  • Liabilities and Shareholders Equity climbed to $2.3 billion in Q1 2026 per LNTH's latest filing, from $2.2 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.3 billion in Q1 2026 and bottomed at $933.2 million in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $1.7 billion across 5 years, with a median of $1.8 billion in 2024.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 52.96% — and 2025, when it increased 9.09%.
  • Lantheus Holdings' Liabilities and Shareholders Equity stood at $1.3 billion in 2022, then increased by 24.97% to $1.7 billion in 2023, then grew by 19.94% to $2.0 billion in 2024, then increased by 12.48% to $2.2 billion in 2025, then increased by 5.35% to $2.3 billion in 2026.
  • Business Quant data shows LNTH's Liabilities and Shareholders Equity at $2.3 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 39.86 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 6.18 Bn
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn 2.41 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.41 Bn
Mar 31, 2026 2.35 Bn
Dec 31, 2025 2.23 Bn
Sep 30, 2025 2.28 Bn
Jun 30, 2025 2.12 Bn
Mar 31, 2025 2.06 Bn
Dec 31, 2024 1.98 Bn
Sep 30, 2024 2.05 Bn
Jun 30, 2024 1.94 Bn
Mar 31, 2024 1.83 Bn
Dec 31, 2023 1.65 Bn
Sep 30, 2023 1.52 Bn
Jun 30, 2023 1.34 Bn
Mar 31, 2023 1.35 Bn
Dec 31, 2022 1.32 Bn
Sep 30, 2022 1.10 Bn
Jun 30, 2022 1.01 Bn
Mar 31, 2022 933.17 Mn
Dec 31, 2021 863.78 Mn
Sep 30, 2021 847.82 Mn